Home | Welcome to Contract Pharma   
Last Updated Wednesday, August 20 2014
Print

Breaking News

February 28, 2013
Goodbody vet joins executive management team  Read More »
February 28, 2013
To develop compounds for the treatment of lupus  Read More »
February 28, 2013
Expands global injectables platform, market reach  Read More »
February 27, 2013
Receives 510K clearance from FDA  Read More »
February 27, 2013
Araxes to receive upfront payment and R&D funding, eligible for royalties  Read More »
February 27, 2013
To develop dual Syk/JAK inhibitors for ophthalmic indications  Read More »
February 27, 2013
Moorhouse responsible for developing new prospects  Read More »
February 27, 2013
Adds single-use sensor technology with Aber partnership  Read More »
February 27, 2013
Denver facility can manufacture schedule II-V controlled substances  Read More »
February 26, 2013
Althea to provide cGMP plasmid DNA for vaccine development  Read More »
February 26, 2013
Aims to provide simpler, more robust early investigations  Read More »
February 26, 2013
Aims to develop new antibiotics targeting Gram-negative bacteria  Read More »
February 26, 2013
Aims to commercialize six products in emerging markets  Read More »
February 26, 2013
Aims to match patients for biomarker oncology trials  Read More »
February 26, 2013
Achieves record 4Q and FY revenue  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On